跳至主要内容
临床试验/NCT00385957
NCT00385957已完成4 期

Comparison of Antiretroviral Activity and Immunological Effect of Two Triple Treatments With and Without Protease Inhibitors in naïve HIV-1-infected Patients With CD4 < 100/mm3

Hospital Clinic of Barcelona12 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2006年10月11日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
70
试验地点
12
主要终点
Proportion of patients with VL below 20 copies/ml in plasma at 12 and 24 months.

研究概览

简要总结

The study analyzes the virological response in plasma and non-plasma compartments, as well as the degree and kinetics of immune reconstitution in 70 treatment-naive patients with CD4 < 100/mm3, when they receive treatment with two nucleoside analogs (NRTI) plus one protease inhibitor (PI) compared with 2 NRTI plus one non-nucleoside (NNRTI).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed HIV-1 infection.
  • Age 18 years or over.
  • No previous antiretroviral therapy.
  • CD4 lymphocyte count of < 100 cells/mL.
  • Patients who, sufficiently informed, give their written consent to participate in the study and undergo the tests and explorations involved in the study.

排除标准

  • Pregnant women, women who are breast feeding, or women who intend to become pregnant during the study period.
  • Currently undergoing treatment for an opportunistic infection (parenteral administration).
  • Any formal contraindication to treatment with the study drugs

结局指标

主要结局

Proportion of patients with VL below 20 copies/ml in plasma at 12 and 24 months.

Proportion of patients with a CD4 count higher than 200 cells/ml at 12 and 24 months.

次要结局

  • Incidence of adverse events
  • CD4 cells (CD45RA+CD45RO-) and memory cells (CD45RA-CD45RO+)
  • Immunophenotypic response at 12 and 24 months (CD4:CD8 quotient,levels of naive
  • and levels of CD8 cells (CD28+ y CD38+)

研究者

申办方类型
Other

研究点 (12)

Loading locations...

相似试验

Immunological and Viral Response to Antiretrovirals... | 临床试验